36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

NCT03266146 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Drug-induced Liver Injury,Chronic

Interventions

DRUG: 36 Weeks Methylprednisolone
DRUG: 48 weeks Methylprednisolone

Sponsor

Beijing 302 Hospital